Glaxosmithkline $3 bn Settlement

            
 
Business Ethics Case Studies|MBA Management Case Studies |Business Ethics Case Study|Ethics Case Studies

ICMR HOME | Case Studies Collection

To download Glaxosmithkline $3 bn Settlement case study (Case Code: BECG126) click on the button below, and select the case from the list of available cases:

Business Ethics Case Studies | Case Study in Management, Operations, Strategies, Business Ethics, Case Studies

OR


Buy With PayPal

Amount to be paid:



Prefer to pay in another currency ?
Select Currency for Payment



Exchange Rates: Click Here
Delivery Details: Click Here

Business Ethics Case Studies
Case Studies Collection
ICMR Home
Business Ethics Short Case Studies
View Detailed Pricing Info
How To Order This Case
Business Case Studies
Case Studies by Area
Case Studies by Industry
Case Studies by Company

Google
Webicmrindia.org



Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.



Chat with us

Strategic Management Formulation, Implementation, & Control, 12e

Please leave your feedback

Leave Your Feedback

ICMR India ICMR India ICMR India ICMR India RSS Feed

Case Details:

Price:

Case Code : BECG126 For delivery in electronic format: Rs. 500;
For delivery through courier (within India): Rs. 500 + Rs. 25 for Shipping & Handling Charges

Themes

Business Ethics / Corporate Law
Case Length : 21 Pages
Period : 1998-2012
Organization : GlaxoSmithKline
Pub Date : 2013
Teaching Note : Available
Countries : US
Industry : Pharmaceutical Industry

Abstract:

GlaxoSmithKline (GSK) pleaded guilty to criminal charges for allegedly promoting its drugs for unapproved uses and failing to report on the safety data about its top selling diabetic drug Avandia, to the Food and Drug Administration (FDA). GSK entered into a settlement agreement with the US Department of Justice and agreed to pay $3 billion to absolve from criminal and civil liability relating to the allegation concerning the nine drugs namely Paxil, Wellbutrin, Advair, Lamictal, Zofran, Imitrex, Lotronex, Flovent, and Valtrex, failure to report safety data for the drug Avandia, and failure to report the best price for certain drugs.

Business Ethics Case Studies | Case Study in Management, Operations, Strategies, Business Ethics, Case Studies

Whistleblowers and the US Justice Department alleged that from 1999 through 2010, GSK was engaged in a fraudulent scheme to deceive and defraud patients, regulators, and federal health programs. The case brings to light the issues and circumstance which led to the lawsuit being filed against GSK and the issues in question in the pharmaceutical industry. The case also brings out the important role played by the whistleblowers in bringing out the unethical practices in the business.

Issues:

To comprehend the business segments of GlaxoSmithKline
To discuss and analyze the essential values and norms pharmaceutical companies should follow
To analyze the ethical issues involved in marketing and promoting pharmaceutical drugs
To debate whether to punish top executives or the firm for the malpractices

Contents:

  Page No.
Introduction 1
GlaxoSmithKline 3
Business Segments 3
Whistleblowers 3
The Drugs in Question 7
Wellbutrin 10
Avandia 11
Other Drugs 12
The Settlement 13
Toward Becoming More Responsible 14
Exhibits 16

Keywords:

Activity Deficit Hyperactivity Disorder (ADHD), Advair, Amerge, American Medical Association, Andrew Witty, Avandia, Cidra Plant, Civil Liabilities, Consumer Healthcare, Corporate Integrity Agreement, Eckard, Emerging Markets, Europe Pharmaceutical and Vaccines, False Claim Act, Food and Drug Administration (FDA), GlaxoSmithKline, Healthcare Fraud, Illegal Market Practices, Imitrex, Lamictal, Medicaid, Off-label promotions, Over-the-counter, Paxil, Pharmaceutical, Pharmaceuticals, Tricare, US Justice Department, US Pharmaceutical and Vaccines, Vaccines, Valtrex, ViiV HealthCare, Wellbutrin, Whistleblower, Zyban

Introduction - Next Page>>


Google





Business Ethics and Corporate Governance Textbook
Text Book - Rs. 500
Textbooks Collection

Business Ethics and Corporate Governance Workbook
Work Book - Rs. 500
Workbooks Collection

Case Studies in Business Ethics - Vol. I

e-Book in Business Ethics
e-Book in Business Ethics

Case Study Volumes Collection

 

Case Studies Links:- Case Studies, Short Case Studies, Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Work Books, Case Study Volumes.